Mobile Application-Based Interventions for Chronic Pain Patients: A Systematic Review and Meta-Analysis of Effectiveness.
Ann-Christin Pfeifer, Riaz Uddin, Paul Schröder-Pfeifer...
https://pubmed.ncbi.nlm.nih.gov/33167300/Actively Recruiting
Led by National Cancer Institute, Naples · Updated on 2025-07-29
40
Participants Needed
2
Research Sites
188 weeks
Total Duration
Researchers are studying how telemedicine can improve the quality of life for cancer patients by helping manage symptoms like pain through remote monitoring and self-assessment. The focus is on developing machine learning algorithms to automatically assess pain levels in advanced cancer patients, as pain is a common and disabling symptom that affects treatment and recovery. This observational study aims to create a database combining clinical data and patient-reported pain information to support this technology. Participants will remain under home care by a specialized outpatient palliative care team while using wearable devices and mobile applications to collect physiological signals such as heart rate, body temperature, blood pressure, and skin response. They will also complete quality-of-life questionnaires and daily pain diaries over about two weeks. The study includes building the IT system to support data collection, conducting a data campaign with at least 40 patients over 6 months, and developing algorithms to predict pain levels from collected data. During the study, patients will be monitored remotely with devices and applications that gather biometric and symptom data. They will provide feedback on pain at scheduled times and during acute episodes using numeric rating scales and multimedia inputs. Researchers will evaluate data quality, patient symptoms, and quality of life through questionnaires. The primary outcome is the development of machine learning tools for pain prediction, with secondary outcomes assessing quality of life. The total data collection period per patient is approximately 10 to 14 days, with ongoing clinical care throughout.
CONDITIONS
Pain ASsessment in CAncer Patients by Machine LEarning (PASCALE)
M
Marco Cascella, MD
A
Arturo Cuomo, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
National Cancer Institute, Naples
Lead Sponsor
Federico II University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 weeks
Participants are observed at home using wearable devices and mobile applications to collect data on pain levels, physiological signals, and quality of life. Pain feedback is provided by participants through daily diaries and during acute pain episodes.
Continuous remote monitoring with wearable devices and mobile app
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Ann-Christin Pfeifer, Riaz Uddin, Paul Schröder-Pfeifer...
https://pubmed.ncbi.nlm.nih.gov/33167300/Paulo Reis-Pina, Peter G Lawlor, António Barbosa
https://pubmed.ncbi.nlm.nih.gov/28919809/Arturo Cuomo, Sabrina Bimonte, Cira Antonietta Forte...
https://pubmed.ncbi.nlm.nih.gov/30863143/Min S H Aung, Sebastian Kaltwang, Bernardino Romera-Paredes...
https://pubmed.ncbi.nlm.nih.gov/30906508/Parisa Rashidi, David A Edwards, Patrick J Tighe
https://pubmed.ncbi.nlm.nih.gov/31408024/S Joseph Sirintrapun, Ana Maria Lopez
https://pubmed.ncbi.nlm.nih.gov/30231354/Thomas Richard Dawes, Ben Eden-Green, Claire Rosten...
https://pubmed.ncbi.nlm.nih.gov/29468939/Sergio Coluccia, Anna Crispo, Alessandro Ottaiano...
https://pubmed.ncbi.nlm.nih.gov/42142332/Marco Cascella, Piergiacomo Di Gennaro, Anna Crispo...
https://pubmed.ncbi.nlm.nih.gov/39097739/Corine Adamse, Marit Gh Dekker-Van Weering, Faridi S van Etten-Jamaludin...
https://pubmed.ncbi.nlm.nih.gov/28696152/National Cancer Institute, Naples
Lead Sponsor
Federico II University
Collaborating Sponsor